0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Meloxicam Tablets Market Research Report 2026
Published Date: 2026-04-10
|
Report Code: QYRE-Auto-8T17320
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Meloxicam Tablets Market Research Report 2024
BUY CHAPTERS

Global Meloxicam Tablets Market Research Report 2026

Code: QYRE-Auto-8T17320
Report
2026-04-10
Pages:126
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Meloxicam Tablets Market

The global Meloxicam Tablets market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Meloxicam Tablets competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The North American market for Meloxicam Tablets is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Meloxicam Tablets is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Meloxicam Tablets include Boehringer Ingelheim, Mylan, Teva Pharmaceutical, Lupin, Apotex, Dr. Reddy's Laboratories, Glenmark Pharmaceuticals, Qilu Pharmaceutical, Yangtze River Pharmaceutical, Zhejiang Xianju Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Meloxicam Tablets market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Meloxicam Tablets. The Meloxicam Tablets market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Meloxicam Tablets market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Meloxicam Tablets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Meloxicam Tablets Market Report

Report Metric Details
Report Name Meloxicam Tablets Market
Segment by Type
  • Original Drug
  • Generic Drug
by Application
  • Rheumatoid Arthritis
  • Osteoarthritis
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boehringer Ingelheim, Mylan, Teva Pharmaceutical, Lupin, Apotex, Dr. Reddy's Laboratories, Glenmark Pharmaceuticals, Qilu Pharmaceutical, Yangtze River Pharmaceutical, Zhejiang Xianju Pharmaceutical, Youcare Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Meloxicam Tablets manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Meloxicam Tablets sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Meloxicam Tablets Market report?

Ans: The main players in the Meloxicam Tablets Market are Boehringer Ingelheim, Mylan, Teva Pharmaceutical, Lupin, Apotex, Dr. Reddy's Laboratories, Glenmark Pharmaceuticals, Qilu Pharmaceutical, Yangtze River Pharmaceutical, Zhejiang Xianju Pharmaceutical, Youcare Pharmaceutical

What are the Application segmentation covered in the Meloxicam Tablets Market report?

Ans: The Applications covered in the Meloxicam Tablets Market report are Rheumatoid Arthritis, Osteoarthritis

What are the Type segmentation covered in the Meloxicam Tablets Market report?

Ans: The Types covered in the Meloxicam Tablets Market report are Original Drug, Generic Drug

1 Meloxicam Tablets Market Overview
1.1 Product Definition
1.2 Meloxicam Tablets by Type
1.2.1 Global Meloxicam Tablets Market Value by Type: 2025 vs 2032
1.2.2 Original Drug
1.2.3 Generic Drug
1.3 Meloxicam Tablets by Application
1.3.1 Global Meloxicam Tablets Market Value by Application: 2025 vs 2032
1.3.2 Rheumatoid Arthritis
1.3.3 Osteoarthritis
1.4 Global Meloxicam Tablets Market Size Estimates and Forecasts
1.4.1 Global Meloxicam Tablets Revenue 2021–2032
1.4.2 Global Meloxicam Tablets Sales 2021–2032
1.4.3 Global Meloxicam Tablets Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Meloxicam Tablets Market Competition by Manufacturers
2.1 Global Meloxicam Tablets Sales Market Share by Manufacturers (2021–2026)
2.2 Global Meloxicam Tablets Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Meloxicam Tablets Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Meloxicam Tablets, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Meloxicam Tablets, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Meloxicam Tablets, Product Types and Applications
2.7 Global Key Manufacturers of Meloxicam Tablets, Date of Entry into the Industry
2.8 Global Meloxicam Tablets Market Competitive Situation and Trends
2.8.1 Global Meloxicam Tablets Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Meloxicam Tablets Players Market Share by Revenue
2.8.3 Global Meloxicam Tablets Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Meloxicam Tablets Market Scenario by Region
3.1 Global Meloxicam Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Meloxicam Tablets Sales by Region: 2021–2032
3.2.1 Global Meloxicam Tablets Sales by Region: 2021–2026
3.2.2 Global Meloxicam Tablets Sales by Region: 2027–2032
3.3 Global Meloxicam Tablets Revenue by Region: 2021–2032
3.3.1 Global Meloxicam Tablets Revenue by Region: 2021–2026
3.3.2 Global Meloxicam Tablets Revenue by Region: 2027–2032
3.4 North America Meloxicam Tablets Market Facts & Figures by Country
3.4.1 North America Meloxicam Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Meloxicam Tablets Sales by Country (2021–2032)
3.4.3 North America Meloxicam Tablets Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Meloxicam Tablets Market Facts & Figures by Country
3.5.1 Europe Meloxicam Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Meloxicam Tablets Sales by Country (2021–2032)
3.5.3 Europe Meloxicam Tablets Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Meloxicam Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Meloxicam Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Meloxicam Tablets Sales by Region (2021–2032)
3.6.3 Asia Pacific Meloxicam Tablets Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Meloxicam Tablets Market Facts & Figures by Country
3.7.1 Latin America Meloxicam Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Meloxicam Tablets Sales by Country (2021–2032)
3.7.3 Latin America Meloxicam Tablets Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Meloxicam Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Meloxicam Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Meloxicam Tablets Sales by Country (2021–2032)
3.8.3 Middle East and Africa Meloxicam Tablets Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Meloxicam Tablets Sales by Type (2021–2032)
4.1.1 Global Meloxicam Tablets Sales by Type (2021–2026)
4.1.2 Global Meloxicam Tablets Sales by Type (2027–2032)
4.1.3 Global Meloxicam Tablets Sales Market Share by Type (2021–2032)
4.2 Global Meloxicam Tablets Revenue by Type (2021–2032)
4.2.1 Global Meloxicam Tablets Revenue by Type (2021–2026)
4.2.2 Global Meloxicam Tablets Revenue by Type (2027–2032)
4.2.3 Global Meloxicam Tablets Revenue Market Share by Type (2021–2032)
4.3 Global Meloxicam Tablets Price by Type (2021–2032)
5 Segment by Application
5.1 Global Meloxicam Tablets Sales by Application (2021–2032)
5.1.1 Global Meloxicam Tablets Sales by Application (2021–2026)
5.1.2 Global Meloxicam Tablets Sales by Application (2027–2032)
5.1.3 Global Meloxicam Tablets Sales Market Share by Application (2021–2032)
5.2 Global Meloxicam Tablets Revenue by Application (2021–2032)
5.2.1 Global Meloxicam Tablets Revenue by Application (2021–2026)
5.2.2 Global Meloxicam Tablets Revenue by Application (2027–2032)
5.2.3 Global Meloxicam Tablets Revenue Market Share by Application (2021–2032)
5.3 Global Meloxicam Tablets Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Company Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Meloxicam Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Boehringer Ingelheim Meloxicam Tablets Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 Mylan
6.2.1 Mylan Company Information
6.2.2 Mylan Description and Business Overview
6.2.3 Mylan Meloxicam Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Mylan Meloxicam Tablets Product Portfolio
6.2.5 Mylan Recent Developments/Updates
6.3 Teva Pharmaceutical
6.3.1 Teva Pharmaceutical Company Information
6.3.2 Teva Pharmaceutical Description and Business Overview
6.3.3 Teva Pharmaceutical Meloxicam Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Teva Pharmaceutical Meloxicam Tablets Product Portfolio
6.3.5 Teva Pharmaceutical Recent Developments/Updates
6.4 Lupin
6.4.1 Lupin Company Information
6.4.2 Lupin Description and Business Overview
6.4.3 Lupin Meloxicam Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Lupin Meloxicam Tablets Product Portfolio
6.4.5 Lupin Recent Developments/Updates
6.5 Apotex
6.5.1 Apotex Company Information
6.5.2 Apotex Description and Business Overview
6.5.3 Apotex Meloxicam Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Apotex Meloxicam Tablets Product Portfolio
6.5.5 Apotex Recent Developments/Updates
6.6 Dr. Reddy's Laboratories
6.6.1 Dr. Reddy's Laboratories Company Information
6.6.2 Dr. Reddy's Laboratories Description and Business Overview
6.6.3 Dr. Reddy's Laboratories Meloxicam Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Dr. Reddy's Laboratories Meloxicam Tablets Product Portfolio
6.6.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.7 Glenmark Pharmaceuticals
6.7.1 Glenmark Pharmaceuticals Company Information
6.7.2 Glenmark Pharmaceuticals Description and Business Overview
6.7.3 Glenmark Pharmaceuticals Meloxicam Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Glenmark Pharmaceuticals Meloxicam Tablets Product Portfolio
6.7.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.8 Qilu Pharmaceutical
6.8.1 Qilu Pharmaceutical Company Information
6.8.2 Qilu Pharmaceutical Description and Business Overview
6.8.3 Qilu Pharmaceutical Meloxicam Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Qilu Pharmaceutical Meloxicam Tablets Product Portfolio
6.8.5 Qilu Pharmaceutical Recent Developments/Updates
6.9 Yangtze River Pharmaceutical
6.9.1 Yangtze River Pharmaceutical Company Information
6.9.2 Yangtze River Pharmaceutical Description and Business Overview
6.9.3 Yangtze River Pharmaceutical Meloxicam Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Yangtze River Pharmaceutical Meloxicam Tablets Product Portfolio
6.9.5 Yangtze River Pharmaceutical Recent Developments/Updates
6.10 Zhejiang Xianju Pharmaceutical
6.10.1 Zhejiang Xianju Pharmaceutical Company Information
6.10.2 Zhejiang Xianju Pharmaceutical Description and Business Overview
6.10.3 Zhejiang Xianju Pharmaceutical Meloxicam Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Zhejiang Xianju Pharmaceutical Meloxicam Tablets Product Portfolio
6.10.5 Zhejiang Xianju Pharmaceutical Recent Developments/Updates
6.11 Youcare Pharmaceutical
6.11.1 Youcare Pharmaceutical Company Information
6.11.2 Youcare Pharmaceutical Description and Business Overview
6.11.3 Youcare Pharmaceutical Meloxicam Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Youcare Pharmaceutical Meloxicam Tablets Product Portfolio
6.11.5 Youcare Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Meloxicam Tablets Industry Chain Analysis
7.2 Meloxicam Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Meloxicam Tablets Production Mode & Process Analysis
7.4 Meloxicam Tablets Sales and Marketing
7.4.1 Meloxicam Tablets Sales Channels
7.4.2 Meloxicam Tablets Distributors
7.5 Meloxicam Tablets Customer Analysis
8 Meloxicam Tablets Market Dynamics
8.1 Meloxicam Tablets Industry Trends
8.2 Meloxicam Tablets Market Drivers
8.3 Meloxicam Tablets Market Challenges
8.4 Meloxicam Tablets Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Meloxicam Tablets Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Meloxicam Tablets Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Meloxicam Tablets Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Meloxicam Tablets Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Meloxicam Tablets Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Meloxicam Tablets Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Meloxicam Tablets Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Meloxicam Tablets Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Meloxicam Tablets, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Meloxicam Tablets, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Meloxicam Tablets, Product Types and Applications
 Table 12. Global Key Manufacturers of Meloxicam Tablets, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Meloxicam Tablets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Meloxicam Tablets Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Meloxicam Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Meloxicam Tablets Sales by Region (K Units), 2021–2026
 Table 18. Global Meloxicam Tablets Sales Market Share by Region (2021–2026)
 Table 19. Global Meloxicam Tablets Sales by Region (K Units), 2027–2032
 Table 20. Global Meloxicam Tablets Sales Market Share by Region (2027–2032)
 Table 21. Global Meloxicam Tablets Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Meloxicam Tablets Revenue Market Share by Region (2021–2026)
 Table 23. Global Meloxicam Tablets Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Meloxicam Tablets Revenue Market Share by Region (2027–2032)
 Table 25. North America Meloxicam Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Meloxicam Tablets Sales by Country (K Units), 2021–2026
 Table 27. North America Meloxicam Tablets Sales by Country (K Units), 2027–2032
 Table 28. North America Meloxicam Tablets Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Meloxicam Tablets Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Meloxicam Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Meloxicam Tablets Sales by Country (K Units), 2021–2026
 Table 32. Europe Meloxicam Tablets Sales by Country (K Units), 2027–2032
 Table 33. Europe Meloxicam Tablets Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Meloxicam Tablets Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Meloxicam Tablets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Meloxicam Tablets Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Meloxicam Tablets Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Meloxicam Tablets Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Meloxicam Tablets Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Meloxicam Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Meloxicam Tablets Sales by Country (K Units), 2021–2026
 Table 42. Latin America Meloxicam Tablets Sales by Country (K Units), 2027–2032
 Table 43. Latin America Meloxicam Tablets Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Meloxicam Tablets Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Meloxicam Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Meloxicam Tablets Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Meloxicam Tablets Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Meloxicam Tablets Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Meloxicam Tablets Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Meloxicam Tablets Sales (K Units) by Type (2021–2026)
 Table 51. Global Meloxicam Tablets Sales (K Units) by Type (2027–2032)
 Table 52. Global Meloxicam Tablets Sales Market Share by Type (2021–2026)
 Table 53. Global Meloxicam Tablets Sales Market Share by Type (2027–2032)
 Table 54. Global Meloxicam Tablets Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Meloxicam Tablets Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Meloxicam Tablets Revenue Market Share by Type (2021–2026)
 Table 57. Global Meloxicam Tablets Revenue Market Share by Type (2027–2032)
 Table 58. Global Meloxicam Tablets Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Meloxicam Tablets Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Meloxicam Tablets Sales (K Units) by Application (2021–2026)
 Table 61. Global Meloxicam Tablets Sales (K Units) by Application (2027–2032)
 Table 62. Global Meloxicam Tablets Sales Market Share by Application (2021–2026)
 Table 63. Global Meloxicam Tablets Sales Market Share by Application (2027–2032)
 Table 64. Global Meloxicam Tablets Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Meloxicam Tablets Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Meloxicam Tablets Revenue Market Share by Application (2021–2026)
 Table 67. Global Meloxicam Tablets Revenue Market Share by Application (2027–2032)
 Table 68. Global Meloxicam Tablets Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Meloxicam Tablets Price (US$/Unit) by Application (2027–2032)
 Table 70. Boehringer Ingelheim Company Information
 Table 71. Boehringer Ingelheim Description and Business Overview
 Table 72. Boehringer Ingelheim Meloxicam Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Boehringer Ingelheim Meloxicam Tablets Product
 Table 74. Boehringer Ingelheim Recent Developments/Updates
 Table 75. Mylan Company Information
 Table 76. Mylan Description and Business Overview
 Table 77. Mylan Meloxicam Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Mylan Meloxicam Tablets Product
 Table 79. Mylan Recent Developments/Updates
 Table 80. Teva Pharmaceutical Company Information
 Table 81. Teva Pharmaceutical Description and Business Overview
 Table 82. Teva Pharmaceutical Meloxicam Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Teva Pharmaceutical Meloxicam Tablets Product
 Table 84. Teva Pharmaceutical Recent Developments/Updates
 Table 85. Lupin Company Information
 Table 86. Lupin Description and Business Overview
 Table 87. Lupin Meloxicam Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Lupin Meloxicam Tablets Product
 Table 89. Lupin Recent Developments/Updates
 Table 90. Apotex Company Information
 Table 91. Apotex Description and Business Overview
 Table 92. Apotex Meloxicam Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Apotex Meloxicam Tablets Product
 Table 94. Apotex Recent Developments/Updates
 Table 95. Dr. Reddy's Laboratories Company Information
 Table 96. Dr. Reddy's Laboratories Description and Business Overview
 Table 97. Dr. Reddy's Laboratories Meloxicam Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Dr. Reddy's Laboratories Meloxicam Tablets Product
 Table 99. Dr. Reddy's Laboratories Recent Developments/Updates
 Table 100. Glenmark Pharmaceuticals Company Information
 Table 101. Glenmark Pharmaceuticals Description and Business Overview
 Table 102. Glenmark Pharmaceuticals Meloxicam Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Glenmark Pharmaceuticals Meloxicam Tablets Product
 Table 104. Glenmark Pharmaceuticals Recent Developments/Updates
 Table 105. Qilu Pharmaceutical Company Information
 Table 106. Qilu Pharmaceutical Description and Business Overview
 Table 107. Qilu Pharmaceutical Meloxicam Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Qilu Pharmaceutical Meloxicam Tablets Product
 Table 109. Qilu Pharmaceutical Recent Developments/Updates
 Table 110. Yangtze River Pharmaceutical Company Information
 Table 111. Yangtze River Pharmaceutical Description and Business Overview
 Table 112. Yangtze River Pharmaceutical Meloxicam Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Yangtze River Pharmaceutical Meloxicam Tablets Product
 Table 114. Yangtze River Pharmaceutical Recent Developments/Updates
 Table 115. Zhejiang Xianju Pharmaceutical Company Information
 Table 116. Zhejiang Xianju Pharmaceutical Description and Business Overview
 Table 117. Zhejiang Xianju Pharmaceutical Meloxicam Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Zhejiang Xianju Pharmaceutical Meloxicam Tablets Product
 Table 119. Zhejiang Xianju Pharmaceutical Recent Developments/Updates
 Table 120. Youcare Pharmaceutical Company Information
 Table 121. Youcare Pharmaceutical Description and Business Overview
 Table 122. Youcare Pharmaceutical Meloxicam Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Youcare Pharmaceutical Meloxicam Tablets Product
 Table 124. Youcare Pharmaceutical Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Meloxicam Tablets Distributors List
 Table 128. Meloxicam Tablets Customers List
 Table 129. Meloxicam Tablets Market Trends
 Table 130. Meloxicam Tablets Market Drivers
 Table 131. Meloxicam Tablets Market Challenges
 Table 132. Meloxicam Tablets Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Meloxicam Tablets
 Figure 2. Global Meloxicam Tablets Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Meloxicam Tablets Market Share by Type: 2025 & 2032
 Figure 4. Original Drug Product Picture
 Figure 5. Generic Drug Product Picture
 Figure 6. Global Meloxicam Tablets Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Meloxicam Tablets Market Share by Application: 2025 & 2032
 Figure 8. Rheumatoid Arthritis
 Figure 9. Osteoarthritis
 Figure 10. Global Meloxicam Tablets Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 11. Global Meloxicam Tablets Market Size (US$ Million), 2021–2032
 Figure 12. Global Meloxicam Tablets Sales (K Units), 2021–2032
 Figure 13. Global Meloxicam Tablets Average Price (US$/Unit), 2021–2032
 Figure 14. Meloxicam Tablets Report Years Considered
 Figure 15. Meloxicam Tablets Sales Share by Manufacturers in 2025
 Figure 16. Global Meloxicam Tablets Revenue Share by Manufacturers in 2025
 Figure 17. Top 5 and Top 10 Global Meloxicam Tablets Players: Market Share by Revenue in Meloxicam Tablets in 2025
 Figure 18. Meloxicam Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 19. Global Meloxicam Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 20. North America Meloxicam Tablets Sales Market Share by Country (2021–2032)
 Figure 21. North America Meloxicam Tablets Revenue Market Share by Country (2021–2032)
 Figure 22. United States Meloxicam Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 23. Canada Meloxicam Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Europe Meloxicam Tablets Sales Market Share by Country (2021–2032)
 Figure 25. Europe Meloxicam Tablets Revenue Market Share by Country (2021–2032)
 Figure 26. Germany Meloxicam Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. France Meloxicam Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. U.K. Meloxicam Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Italy Meloxicam Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Russia Meloxicam Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Asia Pacific Meloxicam Tablets Sales Market Share by Region (2021–2032)
 Figure 32. Asia Pacific Meloxicam Tablets Revenue Market Share by Region (2021–2032)
 Figure 33. China Meloxicam Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Japan Meloxicam Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. South Korea Meloxicam Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. India Meloxicam Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Australia Meloxicam Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. China Taiwan Meloxicam Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Southeast Asia Meloxicam Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Latin America Meloxicam Tablets Sales Market Share by Country (2021–2032)
 Figure 41. Latin America Meloxicam Tablets Revenue Market Share by Country (2021–2032)
 Figure 42. Mexico Meloxicam Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Brazil Meloxicam Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Argentina Meloxicam Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Colombia Meloxicam Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Middle East and Africa Meloxicam Tablets Sales Market Share by Country (2021–2032)
 Figure 47. Middle East and Africa Meloxicam Tablets Revenue Market Share by Country (2021–2032)
 Figure 48. Turkey Meloxicam Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Saudi Arabia Meloxicam Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. UAE Meloxicam Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Global Sales Market Share of Meloxicam Tablets by Type (2021–2032)
 Figure 52. Global Revenue Market Share of Meloxicam Tablets by Type (2021–2032)
 Figure 53. Global Meloxicam Tablets Price (US$/Unit) by Type (2021–2032)
 Figure 54. Global Sales Market Share of Meloxicam Tablets by Application (2021–2032)
 Figure 55. Global Revenue Market Share of Meloxicam Tablets by Application (2021–2032)
 Figure 56. Global Meloxicam Tablets Price (US$/Unit) by Application (2021–2032)
 Figure 57. Meloxicam Tablets Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure